Research Offers Vast Family Of New Catalysts For Use In Drug Discovery, Biotechnology

Chemists at the University of California, Riverside have accomplished in the lab what until now was considered impossible: transform a family of compounds which are acids into bases. As our chemistry lab sessions have taught us, acids are substances that taste sour and react with metals and bases (bases are the chemical opposite of acids)…

Methamphetamine Abuse Linked to Parkinson’s Disease

Abuse of methamphetamines/amphetamines may increase the risk for Parkinson’s disease, a new study suggests. Medscape Medical News

HIV Prevention in Women Requires a Full Toolbox

The AIDS case rate for black women is nearly 20 times the rate for white women; new research offers hope for this group that the tide will turn on HIV transmission. Medscape Medical News

Migraine No Barrier to Presidency, Readers Say

(MedPage Today) — When asked if they would vote for a presidential candidate who gets migraines, 61% of the 2,392 respondents to a MedPage Today online poll said “Yes”, and several pointed out that the list of Oval Office inhabitants includes several who had “serious medical issues.”

Washington Watch: Debt Ceiling Crisis Drags On

WASHINGTON (MedPage Today) — As July comes to an end, the U.S. moves closer to defaulting on its credit, and Congress finds itself desperate to reach an agreement on the debt crisis before the August 2 deadline.

Group Critical of Delay in NIH Disclosure Rule

WASHINGTON (MedPage Today) — A government watchdog group said it’s concerned that the Obama administration may be trying to “weaken or block” parts of a proposed rule that would require researchers funded by the National Institutes of Health to disclose more information about their financial ties to industry.

UH Case Medical Center to commence Phase 1 clinical trial on TMC207

University Hospitals Case Medical Center will begin a Phase 1 clinical trial on a new experimental anti-tuberculosis drug called TMC207.

UH Rainbow physicians to participate in two new clinical trials with AsthmaNet

Physicians at University Hospitals (UH) Rainbow Babies and Children’s Hospital are participating in two new clinical trials with the national research consortium AsthmaNet.

EGT Transfers CGMP Vector For Gene Therapy Trial

Errant Gene Therapeutics, LLC (”EGT”), a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center (”MSKCC”). TNS 9.55…

Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations For OFIRMEV® (acetaminophen) Injection

Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV® (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg…